Latest South America News

EAU Lithium has committed to acquiring Vulcan's proven A-DLE Pilot Plant 4 from Germany, strengthening its capacity to optimise lithium extraction from Bolivian brines and supporting strategic deployment of VULSORB® technology.

Anson Resources and POSCO Holdings have inked a binding agreement for POSCO to design and operate a $7.2 million Direct Lithium Extraction demonstration plant at the Green River Lithium Project in Utah, aiming to validate proprietary lithium extraction technology and strengthen U.S. battery supply chains.

Boresight Ltd (ASX: BST) is seeking to raise $8 million through a public offer to expand its cost-effective military drone manufacturing, targeting growth in the US and European markets.

Pacific Edge has secured NZ$36.1 million through a combination of a NZ$25.4 million placement and a significantly oversubscribed retail offer, reinforcing its strategic position to expand the Cxbladder cancer diagnostic platform.

Senetas Corporation plans to return $3.5 million to shareholders via an equal capital reduction, reflecting confidence in its cash flow and growth prospects following recent strategic moves.

Solis Minerals has raised A$6 million in a placement strongly backed by institutional investors, including major shareholder PLS Group, to fund imminent drilling at its Brazil Lithium and Cinto Copper projects.

Vita Resources NL is accelerating exploration across its diverse portfolio, expanding drilling at its Ninnis Gold Project in WA and confirming polymetallic upgrades at its ICE Project in Canada.

Flagship Minerals has secured A$2.75 million through a strategic placement led by long-term partners, poised to accelerate feasibility and technical work at its 2.1 million ounce Isidora Gold Project in Chile.

Aguia Resources has implemented optimized narrow vein mining at its Santa Barbara Gold Project in Colombia, pushing head grades to 12 g/t Au and improving recoveries, signaling a step-up in production quality.

Anson Resources and POSCO Holdings have sealed a binding deal for a $7.2 million lithium extraction demonstration plant at Green River, advancing the project from concept to operational validation.

Pacific Edge has raised NZ$25.4 million through an oversubscribed placement priced at NZ$0.17 per share, aiming to bolster operations, support Medicare re-coverage efforts, and advance its bladder cancer diagnostic tests.

Pacific Edge is raising NZ$24 million to shore up its finances and support a crucial Medicare re-coverage bid following a steep revenue drop after losing Medicare reimbursement for its bladder cancer test. The company eyes a draft Medicare policy by September 2026 as a potential turning point.